Terms: = Leukemia AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
6 results:
1. The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor ddr2 in calcific aortic valve stenosis.
Carracedo M; Pawelzik SC; Artiach G; Pouwer MG; Plunde O; Saliba-Gustafsson P; Ehrenborg E; Eriksson P; Pieterman E; Stenke L; Princen HMG; Franco-Cereceda A; Bäck M
Br J Pharmacol; 2022 Oct; 179(19):4709-4721. PubMed ID: 35751904
[TBL] [Abstract] [Full Text] [Related]
2. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
[TBL] [Abstract] [Full Text] [Related]
3. Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia.
Pitini V; Arrigo C; Di Mirto C; Mondello P; Altavilla G
Lung Cancer; 2013 Oct; 82(1):171-2. PubMed ID: 23932362
[TBL] [Abstract] [Full Text] [Related]
4. Extended kinase profile and properties of the protein kinase inhibitor nilotinib.
Manley PW; Drueckes P; Fendrich G; Furet P; Liebetanz J; Martiny-Baron G; Mestan J; Trappe J; Wartmann M; Fabbro D
Biochim Biophys Acta; 2010 Mar; 1804(3):445-53. PubMed ID: 19922818
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
Day E; Waters B; Spiegel K; Alnadaf T; Manley PW; Buchdunger E; Walker C; Jarai G
Eur J Pharmacol; 2008 Dec; 599(1-3):44-53. PubMed ID: 18938156
[TBL] [Abstract] [Full Text] [Related]
6. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract] [Full Text] [Related]
